Rituximab as a second-line treatment for lymphocytic vasculitis of the central nervous system

Saar Anis; Amir Sharabi; Yair Mina; Ainat Klein; Emanuela Cagnano; Ori Elkayam; Tanya Gurevich

Rituximab as a second-line treatment for lymphocytic vasculitis of the central nervous system

Saar Anis^*, Amir Sharabi, Yair Mina, Ainat Klein, Emanuela Cagnano, Ori Elkayam, Tanya Gurevich

^*Corresponding author for this work

Tel Aviv University

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Original language	English
Pages (from-to)	630-632
Number of pages	3
Journal	Israel Medical Association Journal
Volume	18
Issue number	10
State	Published - Oct 2016

Keywords

Lymphocytic vasculitis
Primary central nervous system angiitis
Rituximab

Cite this

@article{894e4ad5fd864ef28ba10f6f31408e94,

title = "Rituximab as a second-line treatment for lymphocytic vasculitis of the central nervous system",

keywords = "Lymphocytic vasculitis, Primary central nervous system angiitis, Rituximab",

author = "Saar Anis and Amir Sharabi and Yair Mina and Ainat Klein and Emanuela Cagnano and Ori Elkayam and Tanya Gurevich",

year = "2016",

month = oct,

language = "אנגלית",

volume = "18",

pages = "630--632",

journal = "Israel Medical Association Journal",

issn = "1565-1088",

publisher = "Israel Medical Association",

number = "10",

}

TY - JOUR

T1 - Rituximab as a second-line treatment for lymphocytic vasculitis of the central nervous system

AU - Anis, Saar

AU - Sharabi, Amir

AU - Mina, Yair

AU - Klein, Ainat

AU - Cagnano, Emanuela

AU - Elkayam, Ori

AU - Gurevich, Tanya

PY - 2016/10

Y1 - 2016/10

KW - Lymphocytic vasculitis

KW - Primary central nervous system angiitis

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=84994493559&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 28471627

AN - SCOPUS:84994493559

SN - 1565-1088

VL - 18

SP - 630

EP - 632

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

IS - 10

ER -

Rituximab as a second-line treatment for lymphocytic vasculitis of the central nervous system

Keywords

Other files and links

Cite this